ANGELA MESSINA: Open Payments
NPI 1962108704 · PLANTATION, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,264 in 44 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $508 · 2025 $1,264
Food & beverage: $1,164Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 23 | $699 |
| ConvaTec Inc. | 1 | $94 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $85 |
| Telix Pharmaceuticals | 3 | $79 |
| Myriad Genetic Laboratories, Inc. | 3 | $77 |
| Antares Pharma, Inc. | 3 | $67 |
| Novartis Pharmaceuticals Corporation | 2 | $47 |
| Teleflex LLC | 1 | $31 |
| Endo USA, Inc. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $24 |
Products named: ERLEADA, RYBREVANT, GENTLECATH GLIDE, Nubeqa, ILLUCCIX, MYRISK, XYOSTED, PLUVICTO.
Industry payments across FL — which companies pay providers there.
